JCIA
OPRX icon

Jackson Creek Investment Advisors’s OptimizeRx OPRX Stock Holding History

Jackson Creek Investment Advisors’s Portfolio OPRX Stock Details OPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-21,819
Closed -$1.87M – 338
2021
Q3 		$1.87M Buy
21,819
+200
+0.9% +$12.5K 0.69% 8
2021
Q2 		$1.34M Buy
+21,619
New +$1.1M 0.5% 26

Other funds holding OPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
GIPM
G2 Investment Partners Management New York $406M AUM 164.47% 1-Year Est. Return

Jackson Creek Investment Advisors's OPRX Position: Q4 2021 in Review

Jackson Creek Investment Advisors sold out of OptimizeRx (OPRX) in Q4 2021, closing a stake of 21,819 shares — an estimated $1.87M sold.

Jackson Creek Investment Advisors first reported a position in OPRX in Q2 2021 and held it in 2 quarters. The position peaked at $1.87M in Q3 2021. 180 funds tracked by Wall St. Rank hold OPRX as of Q4 2021.

  • Jackson Creek Investment Advisors reported no remaining OptimizeRx position as of Q4 2021 after selling out during the quarter.
  • Jackson Creek Investment Advisors sold 21,819 OptimizeRx shares in Q4 2021, an estimated $1.87M.
  • Jackson Creek Investment Advisors first reported a position in OptimizeRx in Q2 2021 and held it in 2 quarters.
  • Jackson Creek Investment Advisors's OptimizeRx position peaked at $1.87M in Q3 2021.
  • 180 funds tracked by Wall St. Rank held OptimizeRx as of Q4 2021.

Based on Jackson Creek Investment Advisors's 13F filing for Q4 2021, filed 1 Feb 2022.